home.social

#kinases — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #kinases, aggregated by home.social.

  1. Interesting J. Med. Chem. paper by the group of Michael Waring. They developed alkynylpyridopyrimidinones that covalently target Cys775 of EGFR to allow development of #CovalentInhibitors even against the C797S resistance mutant.
    pubs.acs.org/doi/10.1021/acs.j
    #Chemistry #ChemBio #DrugDiscovery #Kinases

  2. Interesting J. Med. Chem. paper by the group of Michael Waring. They developed alkynylpyridopyrimidinones that covalently target Cys775 of EGFR to allow development of #CovalentInhibitors even against the C797S resistance mutant.
    pubs.acs.org/doi/10.1021/acs.j
    #Chemistry #ChemBio #DrugDiscovery #Kinases

  3. Interesting J. Med. Chem. paper by the group of Michael Waring. They developed alkynylpyridopyrimidinones that covalently target Cys775 of EGFR to allow development of #CovalentInhibitors even against the C797S resistance mutant.
    pubs.acs.org/doi/10.1021/acs.j
    #Chemistry #ChemBio #DrugDiscovery #Kinases

  4. Interesting J. Med. Chem. paper by the group of Michael Waring. They developed alkynylpyridopyrimidinones that covalently target Cys775 of EGFR to allow development of #CovalentInhibitors even against the C797S resistance mutant.
    pubs.acs.org/doi/10.1021/acs.j
    #Chemistry #ChemBio #DrugDiscovery #Kinases

  5. Interesting J. Med. Chem. paper by the group of Michael Waring. They developed alkynylpyridopyrimidinones that covalently target Cys775 of EGFR to allow development of #CovalentInhibitors even against the C797S resistance mutant.
    pubs.acs.org/doi/10.1021/acs.j
    #Chemistry #ChemBio #DrugDiscovery #Kinases

  6. Inhibition of IRAK4 by microbial trimethylamine blunts metabolic inflammation and ameliorates glycemic control

    Protocols All experimental procedures involving mice were carried out in accordance with UK Home Office, Canadian Council on…
    #NewsBeep #News #Health #GB #general #Kinases #LifeSciences #Metabolism #Metabolomics #Microbiome #type2diabetes #UK #UnitedKingdom
    newsbeep.com/uk/306460/

  7. Insightful talk by Anthe Janssen at #NWOCHAINS. He talked about his research with Dompé Farmaceutica in the framework of #ChemistryNL on using #docking and #MachineLearning-assisted re-scoring to better predict compound binding affinity to #kinases.
    pubs.acs.org/doi/10.1021/acs.j
    #Chemistry #ChemBio #DrugDiscovery
    CC: @LED3hub

  8. Insightful talk by Anthe Janssen at #NWOCHAINS. He talked about his research with Dompé Farmaceutica in the framework of #ChemistryNL on using #docking and #MachineLearning-assisted re-scoring to better predict compound binding affinity to #kinases.
    pubs.acs.org/doi/10.1021/acs.j
    #Chemistry #ChemBio #DrugDiscovery
    CC: @LED3hub

  9. Insightful talk by Anthe Janssen at #NWOCHAINS. He talked about his research with Dompé Farmaceutica in the framework of #ChemistryNL on using #docking and #MachineLearning-assisted re-scoring to better predict compound binding affinity to #kinases.
    pubs.acs.org/doi/10.1021/acs.j
    #Chemistry #ChemBio #DrugDiscovery
    CC: @LED3hub

  10. A true tour-de-force study by the group of Bernhard Küster posted as bioRxiv preprint. They profiled 133 kinase inhibitors in 5 cell lines at 11 doses using #phosphoproteomics with #decryptM to identify 5,318 confident kinase::substrate relationships for 96 human #kinases. biorxiv.org/content/10.1101/20

    #Chemistry #ChemBio #Proteomics #DrugDiscovery #Signalling

  11. A true tour-de-force study by the group of Bernhard Küster posted as bioRxiv preprint. They profiled 133 kinase inhibitors in 5 cell lines at 11 doses using #phosphoproteomics with #decryptM to identify 5,318 confident kinase::substrate relationships for 96 human #kinases. biorxiv.org/content/10.1101/20

    #Chemistry #ChemBio #Proteomics #DrugDiscovery #Signalling

  12. A true tour-de-force study by the group of Bernhard Küster posted as bioRxiv preprint. They profiled 133 kinase inhibitors in 5 cell lines at 11 doses using #phosphoproteomics with #decryptM to identify 5,318 confident kinase::substrate relationships for 96 human #kinases. biorxiv.org/content/10.1101/20

    #Chemistry #ChemBio #Proteomics #DrugDiscovery #Signalling

  13. A true tour-de-force study by the group of Bernhard Küster posted as bioRxiv preprint. They profiled 133 kinase inhibitors in 5 cell lines at 11 doses using #phosphoproteomics with #decryptM to identify 5,318 confident kinase::substrate relationships for 96 human #kinases. biorxiv.org/content/10.1101/20

    #Chemistry #ChemBio #Proteomics #DrugDiscovery #Signalling

  14. A true tour-de-force study by the group of Bernhard Küster posted as bioRxiv preprint. They profiled 133 kinase inhibitors in 5 cell lines at 11 doses using #phosphoproteomics with #decryptM to identify 5,318 confident kinase::substrate relationships for 96 human #kinases. biorxiv.org/content/10.1101/20

    #Chemistry #ChemBio #Proteomics #DrugDiscovery #Signalling

  15. Interesting paper by the group of Peter Tonge in JACS. They studied the detailed kinetics of non-covalent BTK inhibitors. Interesting insights that clinical compounds showed increased residence times, while association rates remained nearly constant. pubs.acs.org/doi/10.1021/jacs.
    #Kinases #DrugDiscovery #Chemistry #ChemBio #BTK #Kinetics

  16. Interesting paper by the group of Peter Tonge in JACS. They studied the detailed kinetics of non-covalent BTK inhibitors. Interesting insights that clinical compounds showed increased residence times, while association rates remained nearly constant. pubs.acs.org/doi/10.1021/jacs.
    #Kinases #DrugDiscovery #Chemistry #ChemBio #BTK #Kinetics

  17. Interesting paper by the group of Peter Tonge in JACS. They studied the detailed kinetics of non-covalent BTK inhibitors. Interesting insights that clinical compounds showed increased residence times, while association rates remained nearly constant. pubs.acs.org/doi/10.1021/jacs.
    #Kinases #DrugDiscovery #Chemistry #ChemBio #BTK #Kinetics

  18. Interesting paper by the group of Peter Tonge in JACS. They studied the detailed kinetics of non-covalent BTK inhibitors. Interesting insights that clinical compounds showed increased residence times, while association rates remained nearly constant. pubs.acs.org/doi/10.1021/jacs.
    #Kinases #DrugDiscovery #Chemistry #ChemBio #BTK #Kinetics

  19. Interesting paper by the group of Peter Tonge in JACS. They studied the detailed kinetics of non-covalent BTK inhibitors. Interesting insights that clinical compounds showed increased residence times, while association rates remained nearly constant. pubs.acs.org/doi/10.1021/jacs.
    #Kinases #DrugDiscovery #Chemistry #ChemBio #BTK #Kinetics